FDA Warns of Children's Deaths Linked to Botox Anti-wrinkle drug and competitor Myobloc under agency safety review
By Steven ReinbergHealthDay Reporter
This article is older than one year and is no longer available.
Last Updated: Feb. 08, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
